BAX Baxter - changes reportable segments to two segments effective Q2 2026 - SEC filing - Pharmaceuticals segment now reported within infusi
BAX Baxter - changes reportable segments to two segments effective Q2 2026 - SEC filing - Pharmaceuticals segment now reported within infusion Therapies & platforms division - SEC filing
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.